PHARMATOUNE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMATOUNE
Largest movements
- Cash +€31,742
up €31,742 (+70.6%), from €44,985 to €76,727
mainly Trade debts (+€46,289) and Short-term financial debts (+€40,000)
- Receivables within one year +€11,978
up €11,978 (+4.3%), from €275,446 to €287,425
of which Trade receivables: +€11,174
- Tangible fixed assets -€11,132
down €11,132 (-2.2%), from €497,591 to €486,459
of which Land and buildings: -€13,075
- Trade debts +€46,289
up €46,289 (+115%), from €40,262 to €86,550
- Short-term financial debts +€40,000
up €40,000 (+80.0%), from €50,000 to €90,000
- Profit (loss) carried forward -€29,781
down €29,781, from €0 to -€29,781
- Debts after one year -€25,235
down €25,235 (-5.9%), from €424,815 to €399,580
- Gross operating margin -€38,494
down €38,494 (-38.5%), from €99,937 to €61,443
- Financial income -€2,145
down €2,145 (-64.0%), from €3,354 to €1,208
- Financial charges +€1,999
up €1,999 (+12.6%), from €15,887 to €17,886
- Staff costs -€1,855
down €1,855 (-3.3%), from €56,276 to €54,421
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €997,883 | €1,029,678 | +€31,795 | +3.2% |
| Fixed assets | 21/28 | €497,666 | €486,534 | -€11,132 | -2.2% |
| Tangible fixed assets | 22/27 | €497,591 | €486,459 | -€11,132 | -2.2% |
| Land and buildings | 22 | €494,286 | €481,211 | -€13,075 | -2.6% |
| Plant, machinery and equipment | 23 | €740 | €0 | -€740 | -100% |
| Furniture and vehicles | 24 | €2,565 | €5,248 | +€2,683 | +105% |
| Financial fixed assets | 28 | €75 | €75 | = | 0.0% |
| Current assets | 29/58 | €500,217 | €543,144 | +€42,927 | +8.6% |
| Stocks and contracts in progress | 3 | €175,731 | €174,522 | -€1,209 | -0.7% |
| Stocks | 30/36 | €175,731 | €174,522 | -€1,209 | -0.7% |
| Amounts receivable within one year | 40/41 | €275,446 | €287,425 | +€11,978 | +4.3% |
| Trade receivables | 40 | €45,605 | €56,779 | +€11,174 | +24.5% |
| Other amounts receivable | 41 | €229,841 | €230,646 | +€805 | +0.4% |
| Cash at bank and in hand | 54/58 | €44,985 | €76,727 | +€31,742 | +70.6% |
| Deferred charges and accrued income | 490/1 | €4,055 | €4,471 | +€416 | +10.3% |
| Total equity and liabilities | 10/49 | €997,883 | €1,029,678 | +€31,795 | +3.2% |
| Equity | 10/15 | €257,298 | €227,518 | -€29,781 | -11.6% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €244,898 | €244,898 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €243,038 | €243,038 | = | 0.0% |
| Profit (loss) carried forward | 14 | €0 | -€29,781 | -€29,781 | |
| Amounts payable | 17/49 | €740,585 | €802,161 | +€61,576 | +8.3% |
| Amounts payable after more than one year | 17 | €424,815 | €399,580 | -€25,235 | -5.9% |
| Financial debts | 170/4 | €424,815 | €399,580 | -€25,235 | -5.9% |
| Amounts payable within one year | 42/48 | €309,954 | €396,984 | +€87,029 | +28.1% |
| Current portion of amounts payable after more than one year | 42 | €24,607 | €25,235 | +€628 | +2.6% |
| Financial debts | 43 | €50,000 | €90,000 | +€40,000 | +80.0% |
| Credit institutions | 430/8 | €50,000 | €90,000 | +€40,000 | +80.0% |
| Trade debts | 44 | €40,262 | €86,550 | +€46,289 | +115% |
| Suppliers | 440/4 | €40,262 | €86,550 | +€46,289 | +115% |
| Taxes, remuneration and social security | 45 | €8,350 | €7,689 | -€660 | -7.9% |
| Taxes | 450/3 | €463 | €534 | +€71 | +15.3% |
| Remuneration and social security | 454/9 | €7,886 | €7,155 | -€731 | -9.3% |
| Other amounts payable | 47/48 | €186,736 | €187,509 | +€773 | +0.4% |
| Accrued charges and deferred income | 492/3 | €5,816 | €5,597 | -€218 | -3.8% |
| Remuneration, social security and pensions | 62 | €56,276 | €54,421 | -€1,855 | -3.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €17,243 | €17,298 | +€55 | +0.3% |
| Other operating charges | 640/8 | €2,140 | €2,827 | +€686 | +32.1% |
| Gross operating margin | 9900 | €99,937 | €61,443 | -€38,494 | -38.5% |
| Operating profit (loss) | 9901 | €24,278 | -€13,103 | -€37,381 | |
| Financial income | 75/76B | €3,354 | €1,208 | -€2,145 | -64.0% |
| Recurring financial income | 75 | €3,354 | €1,208 | -€2,145 | -64.0% |
| Financial charges | 65/66B | €15,887 | €17,886 | +€1,999 | +12.6% |
| Recurring financial charges | 65 | €15,887 | €17,886 | +€1,999 | +12.6% |
| Profit (loss) for the period before taxes | 9903 | €11,744 | -€29,780 | -€41,525 | |
| Income taxes | 67/77 | €450 | €0 | -€450 | -99.9% |
| Profit (loss) for the period | 9904 | €11,294 | -€29,781 | -€41,075 | |
| Profit (loss) for the period to be appropriated | 9905 | €11,294 | -€29,781 | -€41,075 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.